Premium
Epidermal growth factor increases clathrin‐dependent endocytosis and degradation of claudin‐2 protein in MDCK II cells
Author(s) -
Ikari Akira,
Takiguchi Ayumi,
Atomi Kosuke,
Sugatani Junko
Publication year - 2011
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.22590
Subject(s) - epidermal growth factor , endocytosis , clathrin , microbiology and biotechnology , cycloheximide , biology , chemistry , protein biosynthesis , cell , biochemistry , receptor
Epidermal growth factor (EGF) decreases the mRNA and protein levels of claudin‐2 (CLDN2) in Madin–Darby canine kidney (MDCK) II cells. Here we examined whether EGF affects the stability and intracellular distribution of CLDN2 protein. EGF decreased surface and total levels of CLDN2, which was inhibited by U0126, a MEK inhibitor. CLDN2 was co‐localized at the tight junctions (TJs) with ZO‐1, a scaffolding protein. The fluorescence signal for CLDN2 disappeared on treatment with EGF, which was inhibited by U0126. EGF accelerated the decrease in CLDN2 in the presence of cycloheximide, a translation inhibitor, indicating that EGF reduces the stability of the protein. Chloroquine, a lysosomal protease inhibitor, blocked the EGF‐induced decrease in CLDN2 protein and caused the co‐localization of CLDN2 with Lamp‐1, a marker of lysosome. Monodancylcadaverine, an inhibitor of endocytosis, and clathrin siRNA blocked the EGF‐induced decrease in CLDN2 and the translocation of CLDN2 from the TJs to the lysosome. EGF increased the association of CLDN2 with clathrin and adaptin α which was inhibited by U0126. These results suggest that EGF accelerates clathrin‐dependent endocytosis and lysosomal degradation of CLDN2 protein mediated by the activation of a MEK/ERK pathway. J. Cell. Physiol. 226: 2448–2456, 2011. © 2010 Wiley‐Liss, Inc.